Zymeworks Inc. is a Vancouver-based clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative biotherapeutics targeting cancer. Leveraging its proprietary platforms, the company has established a diverse pipeline that includes antibody-drug conjugates and bispecific therapeutics, aimed at addressing significant unmet medical needs in oncology. With a strong focus on advancing targeted therapies and strategic collaborations, Zymeworks is well-positioned to emerge as a pivotal player in the biopharmaceutical landscape, driving the delivery of transformative treatments to patients.
Click "Analyze" to generate stock analysis
ZYME Price Trend and Signals
ZYME Option Volumes & Open Interests (aggregated)
ZYME Put Call Ratios and IV (aggregated)
ZYME Financials
2025-10-28Somewhat Bullishprice_signal
Yearly high detected.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.